Penile Squamous Cell Carcinoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2016-02-25
Clinical Trial Update: Efficacy and Safety of Cetuximab in Metastatic Penile Carcinoma (PENILANE) [Phase 2]
A Phase 2 trial evaluating cetuximab for metastatic penile squamous cell carcinoma has been withdrawn.